Rick Gonzalez, AbbVie CEO (Pablo Martinez Monsivais/AP Images)
As Humira sales fall, AbbVie focuses on Skyrizi, Rinvoq growth, eyes external combo strategies
AbbVie said Humira, one of the world’s biggest-selling drugs, still brought in $3.5 billion in sales in the third quarter, though …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
